Argonaute proteins are the effectors of diverse modes of small RNA-mediated gene silencing and are guided to appropriate targets by their associated small RNAs 1 . Major Argonaute partners include ~22-nucleotide (nt) microRNAs (miRNAs) and ~21-nt short interfering RNAs (siRNAs) that associate with particular members of the Agoclade subfamily and ~24-nt to 30-nt Piwi-interacting RNAs (piRNAs) that associate with the Piwi-clade subfamily of Argonautes. Much remains to be understood about piRNA biogenesis, but the generation of miRNAs and siRNAs is relatively well documented 2 . siRNAs generally derive from cleavage of double-stranded RNAs (dsRNAs) by the Dicer RNase III enzyme into siRNA duplexes. Loading of these duplexes into Argonautes is followed by maturation into singlestranded siRNA−Argonaute complexes. Primary miRNA transcripts contain hairpins that are excised by the nuclear RNase III Drosha and its dsRNA-binding partner DGCR8 (known as Pasha in invertebrates). The resulting pre-miRNA hairpins are then cleaved in the cytoplasm by Dicer into duplexes of miRNA and passenger (star) strands that load into Argonautes and mature into single-stranded form. In addition, a variety of noncanonical pathways generate functional miRNAs independently of Drosha and/or Dicer by exploiting diverse RNases that normally catalyze the maturation of other types of transcripts 3 . siRNA function is mediated by the cleavage activity of Drosophila AGO2 and vertebrate Ago2, whereas miRNA function requires the Argonaute partner GW182, which associates with Drosophila AGO1 and all four vertebrate Ago-class Argonautes 4 .
a r t i c l e s
Argonaute proteins are the effectors of diverse modes of small RNA-mediated gene silencing and are guided to appropriate targets by their associated small RNAs 1 . Major Argonaute partners include ~22-nucleotide (nt) microRNAs (miRNAs) and ~21-nt short interfering RNAs (siRNAs) that associate with particular members of the Agoclade subfamily and ~24-nt to 30-nt Piwi-interacting RNAs (piRNAs) that associate with the Piwi-clade subfamily of Argonautes. Much remains to be understood about piRNA biogenesis, but the generation of miRNAs and siRNAs is relatively well documented 2 . siRNAs generally derive from cleavage of double-stranded RNAs (dsRNAs) by the Dicer RNase III enzyme into siRNA duplexes. Loading of these duplexes into Argonautes is followed by maturation into singlestranded siRNA−Argonaute complexes. Primary miRNA transcripts contain hairpins that are excised by the nuclear RNase III Drosha and its dsRNA-binding partner DGCR8 (known as Pasha in invertebrates). The resulting pre-miRNA hairpins are then cleaved in the cytoplasm by Dicer into duplexes of miRNA and passenger (star) strands that load into Argonautes and mature into single-stranded form. In addition, a variety of noncanonical pathways generate functional miRNAs independently of Drosha and/or Dicer by exploiting diverse RNases that normally catalyze the maturation of other types of transcripts 3 . siRNA function is mediated by the cleavage activity of Drosophila AGO2 and vertebrate Ago2, whereas miRNA function requires the Argonaute partner GW182, which associates with Drosophila AGO1 and all four vertebrate Ago-class Argonautes 4 .
Homeostatic and feedback mechanisms coordinate levels of miRNAs with their effector proteins or harmonize the levels of small-RNA−biogenesis factors that function within complexes 5 .
For example, in vertebrates and flies an elegant feedback loop normalizes levels of Drosha and DGCR8 (ref. [6] [7] [8] . DGCR8 transcripts are destabilized by 5′ hairpins that are directly cleaved by Drosha, whereas DGCR8 protein is reciprocally unstable in the absence of Drosha. These cross-regulatory interactions maintain the appropriate stoichiometry of the Drosha-DGCR8 complex. Further studies in plant 9, 10 and animal [11] [12] [13] systems uncovered requirements for the Hsp90 machinery in Argonaute loading and/or stability. Hsp90-cochaperone complexes also facilitate loading of Piwi proteins 14 , and loss of piRNA-biogenesis components results in cell-autonomous loss of Piwi protein 15 .
Despite these accumulating links of small-RNA−biogenesis pathways to the stability of their effector Argonautes, multiple previous studies did not reveal alteration of the Drosophila miRNA effector AGO1 upon depletion of miRNA-biogenesis factors in cultured S2 cells [16] [17] [18] [19] . We re-evaluated this in Drosophila by using null-mutant clones of drosha, pasha and Dcr-1, all of which demonstrate reduction of AGO1. We show that AGO1 is degraded by the ubiquitinproteasome system in Drosophila, and AGO1 is detectably stabilized by transgenic expression of miRNAs, demonstrating a homeostatic mechanism. We extend these findings to mammalian cells and show that Ago2 has lower stability in Dicer1-knockout cells. We were able to rescue Ago2 stability by inhibiting the proteasome or by introducing Dicer-independent miR-451−type constructs. Notably, noncleavable pre-miR-451 hairpins associated with Ago2 but did not rescue its stability, which provides evidence that the active miRNA-induced silencing complex (miRISC) and not simply RNA-associated Argonaute is protected from degradation. The deep conservation of a strategy by a r t i c l e s which Argonaute protein levels are sensitive to miRNA availability reflects its importance for appropriate miRNA-effector function.
RESULTS

In vivo stability of fly AGO1 depends on miRNA biogenesis
Tests from several different laboratories, albeit usually conducted for other reasons, have not revealed substantial alteration of the protein level of miRNA effector AGO1 upon knockdown of any miRNAbiogenesis factors [16] [17] [18] [19] . Having generated a panel of mutants in core miRNA factors 8, 20 , we evaluated whether AGO1 protein was sensitive to miRNA biogenesis in Drosophila. We generated homozygous mutant ovarian germline clones by using the Flp-FRT system, which negatively marked mutant cells by the absence of GFP. We stained these with AGO1-specific antibodies 20 , which in ovaries bearing control germline clones detected somatic and germline expression, with higher levels in the oocyte (Fig. 1a) . As expected, germline clones of AGO1 mutants showed decreased staining (Fig. 1a) . Notably, germline clones of pasha and Dcr-1 similarly showed reduction of AGO1 protein (Fig. 1a) , and analysis of three additional Dcr-1 alleles yielded similar results (Supplementary Fig. 1 ).
We confirmed these findings in somatic tissues and used the mosaic analysis with a repressible cell marker (MARCM) system to positively mark mutant clones with GFP. Whereas control MARCM clones in wing imaginal discs did not show alteration of AGO1 levels (Fig. 1b) , clones bearing null alleles of pasha, drosha and Dcr-1 were all strongly deficient for AGO1 protein (Fig. 1b) . In addition, clones of two pasha mutants and six Dcr-1 mutants in larval brain lobes all exhibited decreased AGO1 staining (Supplementary Fig. 2) . Therefore, accumulation of the miRNA effector AGO1 depends on miRNA biogenesis in diverse tissues and developmental stages.
A previous report did not reveal alteration of AGO1 protein level upon depletion of its cofactor GW182 in S2 cells 19 . As GW182 (official gene symbol gw) is encoded on chromosome 4, which is not amenable to mitotic recombination, we used a transgene to induce RNA-interference knockdown of GW182 (GW182-RNAi). We validated that expression of this transgene reduces GW182 protein in a cell-autonomous manner (Fig. 1c) and derepresses the endogenous miRNA target Mei-P26 (refs. 8,21) to similar levels as those seen in pasha, drosha and Dcr-1 clones (Supplementary Fig. 3a) . Notably, depletion of GW182 caused AGO1 protein to accumulate (Fig. 1c) . This was unexpected, given that mammalian GW182 was reported to protect exogenously transfected miRNAs from exonucleolytic degradation 22 .
Mei-P26 is an E3 ubiquitin ligase that binds AGO1 and regulates miRNA levels 23 . However, as mutant clones of drosha, pasha, Dcr-1 and GW182 all deregulate Mei-P26, but only GW182 mutant cells show increased AGO1, we inferred that Mei-P26 was unlikely to be a major determinant of AGO1 stability in imaginal discs. We confirmed this by showing that although clones that misexpress Mei-P26 exhibit compromised growth 21 , they maintain relatively normal levels of AGO1 (Supplementary Fig. 3b ). The opposing effects of loss of core miRNA-biogenesis factors and the loss of GW182 on AGO1 accumulation provided an opportunity for in vivo epistasis analysis. We generated GFP-labeled MARCM clones that were homozygous for a null allele of Dcr-1 and expressed GW182-RNAi. These clones clearly displayed the AGO1 protein loss phenotype (Fig. 1c) , demonstrating that accumulation of AGO1 upon GW182 loss is strictly dependent on active miRNA biogenesis.
Post-transcriptional control of AGO1 stability
With knowledge of these in vivo data, we reassessed the effects in Drosophila S2 cells. Although previous studies confirmed efficient depletion of target proteins and/or accumulation of miRNA precursors, the literature indicates the difficulty of fully depleting mature miRNAs by knockdown of miRNA-biogenesis components 18, [24] [25] [26] . We used a double-knockdown strategy (4-d dsRNA soaking followed by cell-number normalization and an additional 4-d soaking with fresh dsRNA) for maximal efficacy. This protocol yielded strong loss of (Fig. 2a) . In contrast, knockdown of GW182 reproducibly increased AGO1 levels (Fig. 2a) . These effects were paralleled by the behavior of endogenous miR-34, which strongly decreased in abundance upon knockdown of miRNAbiogenesis factors and mildly increased upon GW182 knockdown (Fig. 2b) . The latter result may suggest that AGO1 turnover is altered when the effector complex is disrupted. A population of mature miR-34 was maintained in AGO1-knockdown cells despite near absence of AGO1; these species exhibited an altered length profile ( Fig. 2b) that is likely to reflect sorting to AGO2. We tested independent AGO1 amplicons and observed no reproducible alteration of AGO1 transcripts following knockdown of miRNA-biogenesis factors ( Fig. 2c) , a result suggesting a post-transcriptional mechanism. This was supported by similar AGO1 transcript levels in homozygous pasha larvae as compared to those of wild type (Fig. 2d) .
Overall, our ability to recapitulate phenotypes from mutant clones with S2-cell knockdowns demonstrated that positive regulation of AGO1 stability by miRNA biogenesis is a general phenomenon, and it appears to act post-transcriptionally.
RNAi effector AGO2 is not dependent on siRNA biogenesis
Given these results, we investigated whether the RNAi effector AGO2 was sensitive to siRNA biogenesis. We introduced a hemagglutinin-AGO2 genomic transgene (FH-AGO2) that supports 
Ovaries Heads homozygous mutant, which lacks siRNA-biogenesis capacity and RNAi capacity 28 , and confirmed genotypes by PCR (Fig. 2e) . We extended our previous studies 27 by showing that AGO2 protein levels were unaltered in Dcr-2−null ovaries and heads (Fig. 2f) . Therefore, although both AGO1 and AGO2 are loaded by Hsp90-dependent mechanisms 11, 12 , the miRNA effector AGO1 is uniquely subject to turnover in the unloaded state.
Increasing miRNA transcription can stabilize AGO1 in vivo
We reciprocally asked whether overproduction of miRNAs could influence AGO1 levels. Imaginal-disc clones expressing DsRed or different individual upstream activation sequence (UAS)-miRNA transgenes did not reveal substantial effects on AGO1 protein levels (Fig. 3a) . However, expression of genomic clusters containing three miRNAs (mir-12, mir-283 and mir-304) or four miRNAs (mir-9c, mir-79, mir-9b and mir-306) resulted in clear cell-autonomous accumulation of AGO1 protein (Fig. 3b) . The strongest effects were seen in clones expressing the eight-miRNA cluster containing mir-309, mir-3, mir-286, mir-4, mir-5, mir-6-1, mir-6-2 and mir-6-3 (Fig. 3b) . Thus, increasing AGO1 levels correlated with the number of ectopically expressed miRNAs. In contrast, clonal overexpression of an RNAi trigger to generate ectopic siRNAs (shep-RNAi) did not alter AGO1 (Fig. 3c) . This was consistent with the bulk sorting of siRNAs into the Drosophila RNAi effector AGO2. We also analyzed the effect of ectopic miRNAs in the ovary. Similarly to the results for imaginal discs, ectopic expression of mir-124, but not a nonprocessed mutant mir-124 construct, elevated AGO1 in ovarian follicle cells (Fig. 3d) . Altogether, these data fulfill a homeostatic mechanism in that loss and gain of miRNA biogenesis induce reciprocal effects on AGO1 accumulation.
The ubiquitin-proteasome system limits AGO1 accumulation
We hypothesized that the ubiquitin-proteasome system might mediate AGO1 homeostasis. We exploited a transgene encoding a dominant temperature-sensitive subunit of the proteasome β6 subunit Pros26 (UAS-DTS5), which we expressed along the anterior-posterior boundary of the wing imaginal disc by using ptc-GAL4 (Fig. 3e) . We introduced a heat shock−inducible transgene (hs-AGO1) in the genetic background so that we could monitor the outcome of a pulse of AGO1 expression across a time course, comparing wild-type cells with neighboring cells in which proteasome activity was impaired. After a 15-min heat shock, AGO1 protein levels were greatly elevated throughout the disc, with further accumulation within the DTS5-expressing domain (Fig. 3e) . By 4 h after induction, AGO1 returned to normal endogenous levels throughout the disc except within the DTS5-expressing domain (Fig. 3e) . These data demonstrate that exogenous AGO1 is rapidly turned over by a proteasome-dependent mechanism.
We complemented these tests by assessing whether endogenous AGO1 is regulated by ubiquitination. We were unable to recover imaginal-disc clones expressing an RNAi transgene to the sole ubiquitin-activating enzyme Uba1 (data not shown), probably owing to cell competition or cell lethality. However, we could recover such clones in the ovarian follicular epithelium, and these clones accumulated AGO1 protein (Fig. 3f) . Therefore, endogenous AGO1 protein is restricted by ubiquitination.
Stability of mammalian Ago2 depends on miRNA availability
We sought to extend these findings to mammalian cells. An excellent model is a stable Dicer1 −/− mouse embryonic fibroblast (MEF) cell line that we have extensively characterized 29 . Although western blot analysis detected endogenous mouse Ago2 protein in these cells, timecourse analyses following cycloheximide treatment showed that Ago2 was destabilized in Dicer1 −/− cells (Fig. 4a) . We assessed whether Ago2 accumulation was sensitive to the restoration of endogenous miRNA biogenesis. Transfection of Dicer1 −/− cells with a Flag-Dicer construct rescued processing of endogenous let-7a into mature miRNAs (Fig. 4b) . Concomitant with this, completion of miRNA biogenesis substantially increased Ago2 stability (Fig. 4c) .
We attempted to assess Ago1 but did not detect its endogenous accumulation in Dicer1 −/− cells (Supplementary Fig. 4) . As an alternative, we transfected myc-tagged human Ago1 into Dicer1 −/− cells and observed that its decay was slower than that of endogenous Ago2 (Supplementary Fig. 4b ). However, myc-tagged human Ago2 did not recapitulate the instability of mouse Ago2. Moreover, transfection of either construct impaired the decay of endogenous Ago2 (Supplementary Fig. 4b) . We infer that this may reflect the recruitment of ectopic and endogenous Argonaute proteins into aggregates 30 , whose loading potential and stability control might be altered. We therefore concentrated our further studies on endogenous Ago2.
Ago2 transcript levels in Dicer1 −/− cells were unaltered by cycloheximide or Flag-Dicer plasmid (Fig. 4d) , a result pointing to regulation of Ago2 protein stability. Analogous to genetic (Fig. 4e) . Given the recent report that autophagy regulates Argonaute levels in mammalian cells 31 , we also treated Dicer1 −/− cells with the autophagy inhibitor bafilomycin A1. This did not perturb Ago2 levels during a time course of 2−6 h, even though we confirmed strong inhibition of autophagy by accumulation of LC3-II at all time points (Supplementary Fig. 5a ). Moreover, bafilomycin A1 did not rescue the instability of AGO1 in Drosophila S2 cells depleted of various miRNA-biogenesis factors (Supplementary Fig. 5b ). Double treatments suggested a mild stabilizing effect of bafilomycin A1 in Dicer1 −/− cells beyond the effect of MG132 (Supplementary Fig. 5c ). However, we were cautious to interpret this as a parallel pathway, given the possibility of indirect effects in this triple drug treatment. Notably, we could also improve Ago2 stability in Dicer1 −/− cells just by transfecting them with synthetic siRNAs (Fig. 4f) . Similar findings were reported that synthetic siRNAs stabilize mammalian Argonautes in the presence of Hsp90 inhibitors 13 . These observations implied that RNA-loaded Ago2 is more resistant to degradation.
Genetic rescue of Ago2 stability in Dicer-knockout cells
We tested cellular strategies to rescue miRNA biogenesis in Dicer1 −/− cells. Vertebrate miR-451 matures through a Dicer-independent mechanism that involves direct loading of its short pre-miRNA hairpin into Ago2 and subsequent slicing of the complementary strand and resection of its 3′ end 32 . We have previously shown that functional miR-451 can be efficiently generated in a Drosha-and Dicer-independent fashion by a fusion construct (tRNA−mir-451) comprising tRNA (official symbol TRNAK3) and miRNA genes 33 . We exploited this as a genetic strategy to express mature miRNAs from a nuclear context in Dicer1 −/− MEFs, and these miRNAs were efficiently immunoprecipitated with Ago2 (Fig. 5a ). For comparison, we generated a tRNA−mir-155 fusion that includes the endogenous Dicer substrate pre-miR-155 hairpin. Northern blotting of Ago2 immunoprecipitates from Dicer1 −/− MEFs transfected with these constructs showed that they contain pre-miR-155 hairpin but not mature miR-155 (Fig. 5a) . Northern blotting does not directly demonstrate that the detected small RNAs constitute a substantial fraction of total small RNAs in these cells. We therefore performed end-labeling of total RNAs from Ago2 immunoprecipitates. Notably, we observed that cells transfected with tRNA−mir-451 accumulated specific RNAs in the <30-nt range corresponding to mature miR-451 species (Fig. 5b) . However, cells transfected with tRNA−mir-155 accumulated an ~60-nt band (Fig. 5b) that matched the expected size of pre-miR-155. Therefore, these tRNA constructs generate sufficient levels of small RNAs to affect the total small-RNA pool in Dicer1 −/− cells.
With these validations in hand, we compared the effects of these RNAs on Ago2 levels. Transfection of tRNA−mir-451 substantially rescued instability of Ago2 in Dicer1 −/− cells following cycloheximide treatment (Fig. 5c) . In contrast, tRNA−mir-155 provided only slight improvement of Ago2 stability as compared to empty tRNA Lys vector alone (Fig. 5c) . Immunoprecipitation experiments confirmed the reduction of Ago2 abundance under these conditions ( Supplementary  Fig. 4c) . Therefore, although a population of pre-miRNA hairpins has the capacity to associate with Ago2 in the absence of Dicer (Fig. 5a,b) , these are not competent to protect Ago2 from turnover.
To provide further evidence for this, we generated a tRNA−mir-451 cleavage-mutant construct (tRNA−mir-451CM) that bears centrally bulged sites, a configuration that is competent for Argonaute loading but 29 . We confirmed that tRNA−miR-451CM loads into Ago2 in Dicer1 −/− cells but remains arrested as a pre-miR-451 hairpin (Fig. 5d) . In contrast, cells expressing wild-type tRNA-mir-451 mildly accumulate the hairpin precursor, but Ago2 complexes strictly contain cleaved and matured forms of miR-451 (Fig. 5d) . We observed that tRNA−mir-451CM was unable to stabilize Ago2 (Fig. 5e) , and this provides further evidence that mere RNA association may not suffice for Ago2 stability. We hypothesize that the conformation of pre-miRNA−loaded Argonaute differs from the mature single-stranded complex and that only the latter can achieve full stability in vivo.
Rescue of Drosophila AGO1 by synthetic miRNAs but not siRNAs Finally, we returned to the Drosophila system to ask whether the reintroduction of small RNAs could rescue the instability of AGO1 in cells with impaired miRNA biogenesis. As Dicer-independent miRNAs have not yet been identified in this species, we turned to synthetic small-RNA duplexes. This experimental strategy has the advantage of using the Drosophilaspecific feature of Argonaute sorting to potentially distinguish the impact of siRNA loading from that of miRNA loading on AGO1 stability. We previously used synthetic miR-276a duplexes to dissect the mechanism of AGO1 loading in vitro 34 . Here, we evaluated the capacity of synthetic wild-type miR-276a duplex to repress target sensors when transfected into S2 cells. Both mature and star species of miR-276a are competent for target regulation of cognate luciferase sensors when expressed as primary miRNA transcripts from transfected plasmids 35 (Fig. 5f) . However, we obtained much stronger repression of these sensors in S2 cells transfected with the synthetic miR-276a duplex, a result indicating that this duplex efficiently populates functional Argonaute complexes. We used S2 cells that were doubly treated with GFP, drosha, pasha, or Dcr-1 dsRNA and further introduced either synthetic fully paired siRNA duplexes (used in mammalian cell tests in Fig. 4f ) or miR-276a duplex. We observed a mild improvement of AGO1 stability in the absence of miRNA biogenesis with the siRNA duplex but observed strong recovery of AGO1 accumulation in the presence of synthetic miR-276a duplex (Fig. 5g) . These tests specifically demonstrate that sorting of small RNAs to AGO1 are indeed required for maintenance of AGO1 stability.
DISCUSSION
Model figures of biogenesis pathways for small RNAs often give the impression that these processes are constitutive, inflexible and inexorable. However, diverse mechanisms that regulate small-RNA biogenesis and function have been uncovered recently 5 . Notably, many of these mechanisms provide homeostatic control over the levels of small-RNA−biogenesis factors and/or their resultant small RNAs. The revised picture is that small-RNA pathways are subject to constant tuning to maintain appropriate levels of the factors involved and to provide systems that permit reversibility or enhancement of small-RNA functions. In this respect, knowledge of small-RNA pathways is now coming to par with that of other signaling pathways and regulatory networks, which are almost universally subject to multilayer regulation.
In this study, we used both Drosophila and mammalian systems to demonstrate sensitive mechanisms that normalize miRNA biogenesis to the abundance of Argonaute effector proteins. Recent structural studies of full-length mammalian Argonaute provide a framework for rationalizing the turnover of unloaded Argonautes, including the observation that Ago2 adopts a protease-resistant, tight structure upon complexation with a small RNA 36, 37 . This perspective is complemented by studies using Hsp90 inhibitors that demonstrate that conformational changes are required to load Argonautes with small RNAs and lead to a stable state [9] [10] [11] [12] [13] .
A recent study reported that loss of miRNA biogenesis in mouse embryonic stem cells (bearing DGCR8 or Dicer1 mutations) results in post-transcriptional loss of Ago2 protein 38 . Our work agrees with this and broadens this concept across multiple species, in both germ line and somatic cells. In addition, our studies highlight not only that loss of miRNA biogenesis destabilizes Argonaute proteins, but also that Argonaute proteins are normally made in excess and can be stabilized by increasing miRNA transcription. We demonstrated this by clonal analysis of single-copy inducible miRNA transgenes within intact animals and showed that activating the transcription of various miRNA loci was sufficient to elevate AGO1 protein levels (Fig. 3) .
Such a homeostatic response was not expected, given that elevation of Argonaute proteins can increase the abundance of siRNAs 39 or miRNAs 40, 41 and that quantitative measurements indicated an excess of miRNA species over Argonaute proteins 42 , at least in certain systems. We note that the effects of elevated Argonaute proteins has mostly been studied with respect to cotransfected miRNA constructs and siRNAs; thus, influence of this manipulation on endogenous miRNA pools remains to be understood. In addition, miRNA/Argonaute stoichiometry was examined in cancer cells 42 and remains to be studied in tissues or at least in primary cells 43 . We believe that it makes physiological sense for Argonaute proteins to be initially made in excess relative to miRNAs because if Argonautes were limiting then tissuespecific changes in the transcription of miRNA loci might result in competition for Argonaute occupancy. This would not rule out that the transcription of Argonaute genes might be regulated to help normalize their protein levels with overall tissue-specific changes in bulk miRNA transcription; perhaps both strategies work in concert.
Notably, we find that the Drosophila RNAi effector AGO2 is not sensitive to the status of siRNA biogenesis. Why might homeostatic mechanisms exist specifically for miRNA-effector Argonautes? One possibility is to prevent the misloading of unintended small RNAs into miRISCs because this regulatory complex has the capacity to regulate off-targets bearing minimal sequence complementarity. We showed that the RNAi pathway actively prevents loading of endogenous siRNAs into AGO1 (ref. 27) , and a trimming and tailing mechanism further culls siRNAs loaded into miRISCs on the basis of their atypically extensive target pairing 44 . The destabilization of unloaded miRNA effectors may be another mechanism to ensure purity of this Argonaute pool. However, the rarity of endogenous, extensively paired 'siRNA-type' targets may mean that misloading of AGO2 is better tolerated. Perhaps a pool of unloaded AGO2 may ensure a timely response to viral infections by allowing large amounts of viral siRNA-dependent RISC to be generated quickly.
The ubiquitin-proteasome system contributes to Argonaute homeostasis, and this extends a theme from other recent studies that demonstrate temporal or cell state−specific ubiquitination and degradation of Argonaute and Piwi proteins 45, 46 . In support of this notion, we used not only chemical inhibitors but also genuine genetic manipulations of the proteasome. We showed that Drosophila AGO1 is increased in cells depleted of Uba1 (the sole Drosophila ubiquitin-activating enzyme) or that express a dominant-negative proteasome subunit (DTS5), indicating that excess miRNA Argonaute effectors are being turned over in vivo. Recently, autophagy was reported to degrade Ago2 in HeLa cells 31 and in DGCR8 −/− embryonic stem cells 38 . The latter work is consistent with conclusions regarding instability of Argonautes in the absence of miRNA biogenesis. However, we did not observe substantial effects of autophagy inhibition in either our Drosophila or mouse cell-culture systems, even though we confirmed defective autophagy by accumulation of LC3-II ( Supplementary  Fig. 5 ). It is conceivable that both degradation pathways contribute npg a r t i c l e s to the observed phenomenon, with the relative contributions being determined by cell type and culture conditions. Finally, our studies used new noncanonical miRNA-expression vectors to distinguish between the pre-miRNA−associated Argonaute state and the mature, functional miRISC state. In particular, our results indicate that Argonaute stability is not only sensitive to the overall availability of miRNAs but also to its state as a mature complex (Fig. 5) . Therefore, even though Dicer1 −/− cells accumulate premiRNAs, and these can associate with Argonaute proteins 47 , RNA association alone does not seem sufficient for full stability. In combination with our data that Drosophila AGO1 can be stabilized by increasing miRNA transcription, we conclude that metazoan cells have sensitive mechanisms that actively harmonize the levels of miRNA-effector Argonautes to the status of miRNA biogenesis.
METHODS
Methods and any associated references are available in the online version of the paper.
